Literature DB >> 18264669

Reversal of elevated pancreatic enzymes after Helicobacter pylori eradication.

Maria P Dore, Antonia R Sepulveda, Antonietta Pedroni, Giuseppe Realdi, Giuseppe Delitala.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18264669     DOI： 10.1007/s11739-008-0117-3

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  5 in total

Review 1.  Extradigestive manifestations of Helicobacter pylori infection: fact and fiction.

Authors:  G Realdi; M P Dore; L Fastame
Journal:  Dig Dis Sci       Date:  1999-02       Impact factor: 3.199

2.  Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection.

Authors:  M P Dore; D Y Graham; R Mele; L Marras; S Nieddu; A Manca; G Realdi
Journal:  Am J Gastroenterol       Date:  2002-04       Impact factor: 10.864

Review 3.  Chronic pancreatitis.

Authors:  M L Steer; I Waxman; S Freedman
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

4.  A concept on the role of Helicobacter pylori infection in autoimmune pancreatitis.

Authors:  J Kountouras; C Zavos; D Chatzopoulos
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

5.  Helicobacter species ribosomal DNA in the pancreas, stomach and duodenum of pancreatic cancer patients.

Authors:  Hans-Olof Nilsson; Unne Stenram; Ingemar Ihse; Torkel Wadstrom
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742
  5 in total
  2 in total

Review 1.  Helicobacter pylori and pancreatic diseases.

Authors:  Milutin Bulajic; Nikola Panic; Johannes Matthias Löhr
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

2.  Pancreatic Cancer Cell-Derived Exosomes Promote Lymphangiogenesis by Downregulating ABHD11-AS1 Expression.

Authors:  Xulin Zhou; Fengyun Zhong; Yongmin Yan; Sihui Wu; Huizhi Wang; Junqiang Liu; Feifan Li; Dawei Cui; Min Xu
Journal:  Cancers (Basel)       Date:  2022-09-23       Impact factor: 6.575
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.